Tecfidera FDA Approval History
FDA Approved: Yes (First approved March 27, 2013)
Brand name: Tecfidera
Generic name: dimethyl fumarate
Dosage form: Delayed-Release Capsules
Previous Name: BG-12
Company: Biogen Idec
Treatment for: Multiple Sclerosis
Tecfidera (dimethyl fumarate) is an oral Nrf2 pathway activator for the treatment of relapsing forms of multiple sclerosis.
Development timeline for Tecfidera
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.